Skip to content
MedsAcross

Medicine

Niacin 500 mg tablet

Niacin · Oral
Available on requestPrescription onlyUS FDAGeneric name

Niacin 500 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Niacin
Brand
Sold under the generic name
Strength
500 mg
Dosage form
Tablet
Route
Oral
Packs
90 tablets, 100 tablets, 30 tablets and 3 more
Manufacturers
Macleods PharmaceuticalsIndiaRedmont PharmaceuticalsEmerald Therapeutics
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C04AC01 Niacin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 May 2000
Identifiers
RxCUI 198024, 1098134, 1098141DailyMed set ID f51f7e6d-b132-48d8-8bb1-54203472f0d8, 52ad4a6a-81cc-4b03-b8b1-3bd9a1d4064e, 5fceeb58-e54d-43c1-8abb-33feea69d663NDC 71741-020, 33342-187, 72919-420Application ANDA040378, ANDA204934

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
90 tablet in 1 bottle33342-187-10Macleods PharmaceuticalsIndia3 March 2022
100 tablet in 1 bottle33342-187-11Macleods PharmaceuticalsIndia3 March 2022
90 tablet in 1 bottle72919-420-90Emerald Therapeutics31 March 2021
30 tablet in 1 bottle71741-020-30Redmont Pharmaceuticals12 December 2025
60 tablet in 1 bottle71741-020-60Redmont Pharmaceuticals12 December 2025
90 tablet in 1 bottle71741-020-90Redmont Pharmaceuticals16 December 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 July 1957Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Niacin 500 mg tablet.

Compare 1

Other strengths and forms of Niacin

Clinical summary

Niacin is a nicotinic acid indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate, among other approved uses. MedsAcross supplies Niacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Niacin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Niacin 500 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.